Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has the proven expertise, superior technologies and flexible solutions at the right scale to help ensure successful product development, launch, tech transfer and global reliable supply. Employing nearly 13,000 professionals, including around 2,400 scientists across more than 35 locations, Catalent invests in the development of over 700 projects and supports the launch of over 200 products each year. As a preferred partner for personalised medicines, consumer health brand extensions, and blockbuster drugs, Catalent is committed to optimising product development, launch, and full life-cycle supply on a global scale.

Services include:
- Small Molecule
- Biologics
- Cell and Gene Therapy
- Drug Product Formulation (FDF)
- Research & Development
- Clinical Trial Materials
- Packaging
- Regulatory Services
- Analytical Methods Development
- Solid Dosage
- Injectables
- Clinical Dose
- Clinical Packaging
- Containment
- Analytical Services
- Protein and Peptide
- APIs (Active Pharmaceutical Ingredients)
- 505(b)(2)
- Accelerated Stability Studies
- Aerosol
- Agglomeration
- Anti-Counterfeiting Technology
- API Solubilization Technologies
- Aseptic Fill/Finish
- Assay Development
- Auditing
- Barcoding
- Bioanalytical Services
- Bioavailability Studies
- Biological Testing
- Process Development
- Biomarker Research
- Bioprocess Validation
- Bioprocessing
- Disposable/Single-Use
- Biosimilars
- Cell Culture Media Development
- Chemical Analysis
- Chromatography
- Clinical Supply Management
- Clinical Trials Management
- Chemistry (CMC)
- Manufacturing
- Cold Chain Management
- Comparator Drug Blinding
- Comparator Drug Purchasing
- Consulting
- Quality Management Systems
- Regulatory
- Contract Development and Manufacturing (CDMO)
- Contract Manufacturing (CMO)
- Contract Packaging
- Custom Synthesis
- Dissolution Testing
- Distillation
- Distribution
- Clinical Trials
- DMF Establishment / Maintenance
- Dosage Form Development
- Drug Delivery Devices
- Contract Development
- Efficacy Testing
- Encapsulation
- Environmental Analysis
- Testing
- Feasibility Studies
- Filling
- Capsule
- Cartridge
- Syringe
- Vials
- Fluid Bed Processing
- Formulation Development
- Controlled Release
- Granulation
- High Throughput Screening
- Hot Melt Extrusion
- IND/NDA Submissions
- Lot Release Testing
- Lyophilization
- Mammalian Cell Culture
- Antibody-Drug Conjugates
- Aseptic Fill-Finish
- Controlled Substances
- Creams & Ointments
- Cytotoxic & High Potency Compounds
- Dose Form
- Non-Sterile
- Sterile
- Gels
- Liquids
- Nasal Delivery
- Nutraceuticals
- Ophthalmics
- Oral Drug Delivery
- Orally Dispersible Tablet
- OTC
- Parenterals
- Small Volume
- Soft Gels
- Solutions & Suspensions
- Sustained Release
- Pre-filled
- Tablets
- Topicals
- Vaccines
- Mass Spectrometry
- Metabolic Analysis
- Microbiological Testing
- Micronization
- Mixing & Blending
- Organic Synthesis
- Anti-Counterfeiting
- Banding
- Blister
- Cold Form
- Asceptic Fill-Finish
- Glass
- Labelling
- Unit Dosage
- Particle Characterization
- Particle Size Analysis
- Particle Size Classification
- Pharmacogenomics
- Physical Testing
- Pilot-Scale Filling
- Preclinical Testing
- Preformulation
- Process Analytical Technology (PAT)
- Process Validation Studies
- Protein Extraction/Purification
- Quality QA/QC
- Regulatory Affairs Consultants
- Scale-Up
- Screening
- Classifying
- Spray Drying
- Stability Studies
- Sterile Filling
- Sterility Testing
- Storage
- Sustained Release Delivery Systems
- Tablet Coating
- Technology Transfer
- Validation
- Warehousing
- Contract Research

Catalent remains dedicated to facilitating innovative pharmaceutical, biotechnology, and consumer health partnerships, ensuring reliable supply and improved health outcomes for patients worldwide. For more information, visit catalent.com.